Three Prescriptions, Twenty Minutes
Three prescriptions arrive within 20 minutes. (1) Levothyroxine 50 mcg tablets with a handwritten "Synthroid - brand medically necessary, do not substitute." The pharmacy stocks only generic levothyroxine 50 mcg. (2) Warfarin 5 mg, "substitution permitted." The pharmacy is out of 5 mg tablets but has 2.5 mg; the prescriber's office calls back and says "just dispense two of the 2.5 mg tablets per dose." (3) One month later, the same warfarin patient returns: the 5 mg is back in stock, but it is from a different manufacturer, with a visibly different tablet color and shape. The patient is stable at an INR of 2.5.
1. How should the pharmacist handle the levothyroxine prescription marked "brand medically necessary, do not substitute"?
Read the worked answer
Honor the instruction. Do not substitute, and do not dispense generic with a note.
- A "do not substitute" / "brand medically necessary" direction is binding. Substitution authority exists only where the prescriber has not prohibited it, and only for a product that is therapeutically equivalent in active ingredient, strength, dosage form, and route.
- Call the prescriber. If the patient can wait, order the brand. If not, ask the prescriber to authorize the generic in a new prescription - not a verbal aside to the pharmacist.
- If the switch happens, treat it as a clinical event: levothyroxine has a narrow therapeutic index, so changing manufacturer warrants counseling and a TSH recheck in about 6–8 weeks. Document the conversation and the plan.
- What you may not do is dispense the generic because it is what is on the shelf and tell the patient "it's the same drug." That is exactly the substitution the prescriber prohibited.
2. The prescriber's office authorizes "two 2.5 mg tablets per dose." Can the pharmacist dispense on that basis?
Read the worked answer
Yes, as a new prescription - not as a substitution - provided you document it properly.
- A change in strength is not product selection; it is a new order. For a non-controlled drug, an oral prescription from the prescriber or the prescriber's authorized agent is valid.
- Reduce it to writing as a new prescription: warfarin 2.5 mg tablets, two tablets per dose, with the total quantity, the date, the name and title of the caller, and a read-back. Note clearly that it replaces the 5 mg order.
- Then counsel: doubling tablets increases the chance of a missed or halved dose; recommend a pill organizer; warn about the appearance change; and note the cost issue - two 2.5 mg tablets may cost more than one 5 mg tablet, which is worth raising before the patient is at the counter.
- If this had been a Schedule II drug, an oral order changing the strength would not be valid outside the narrow emergency exception.
3. A month later the 5 mg warfarin is back in stock from a different manufacturer, with a different tablet appearance. What is required before dispensing, and what counseling and follow-up are indicated?
Read the worked answer
This is generic-to-generic selection, not therapeutic substitution - but warfarin is where manufacturer changes matter clinically.
- Same drug, same strength, same dosage form, different manufacturer generally does not require prescriber authorization. Prescriber permission is needed only where the prescriber prohibited substitution or where the product is not therapeutically equivalent.
- Warfarin has a narrow therapeutic index, and changes in excipients or manufacture can shift INR. Practical steps:
- Tell the patient the tablet will look different and that this is the same medicine.
- Warn against mixing old and new tablets to "use them up."
- Recommend an INR check within a few days to two weeks depending on how closely the prescriber follows the patient, and tell the patient what bleeding signs to watch for.
- Document the manufacturer, lot number, and NDC dispensed, plus the counseling provided. If the patient's plan requires brand warfarin for exactly this reason, check the preferred product before you substitute.